What WHO wrote about the different types of vaccine strategies on January 12 2021 is at the time of writing still up. Now that there is persistent pressure to inject ever-younger age groups, it is worth recalling the experimental nature of what is injected:
When I looked for details of the viruses that are involved in breakthrough infections on Google Scholar, I found two terms that might explain some of the mechanics on the level of the genetic code of the virus:
Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States
Hepatitis B vaccination: are escape mutant viruses a matter of concern?
While the above is not related to the Corona virus, the terms could help to locate new research as it is published. I tried and found an example in:
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
Another comment: while the article argues for the need to develop new vaccines, they do not mention the human body and its immune system; understandably so, since there would be less grant money and less business for the industry.
A public poll by a Newspaper in Denmark suggested that 2/3 of those that voted were of the opinion that vaccination should be mandatory. That is quite telling when one considers that the campaign operates under an emergency use authorization, and that breakthrough infections of people who are "vaccinated" are common."A nucleic acid vaccine delivers a specific set of instructions to our cells, either as DNA or mRNA, for them to make the specific protein that we want our immune system to recognize and respond to.
The nucleic acid approach is a new way of developing vaccines. Before the COVID-19 pandemic, none had yet been through the full approvals process for use in humans, though some DNA vaccines, including for particular cancers, were undergoing human trials. Because of the pandemic, research in this area has progressed very fast and some mRNA vaccines for COVID-19 are getting emergency use authorization, which means they can now be given to people beyond using them only in clinical trials."
When I looked for details of the viruses that are involved in breakthrough infections on Google Scholar, I found two terms that might explain some of the mechanics on the level of the genetic code of the virus:
Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States
Hepatitis B vaccination: are escape mutant viruses a matter of concern?
While the above is not related to the Corona virus, the terms could help to locate new research as it is published. I tried and found an example in:
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
What does this mean? Does it mean that when more people are vaccinated, the COVID19 virus will adapt to the new environment and create a new mutant/recombinant virus, similar to how some weeds can become resistant to some herbicides, some insects to some insecticides, and some diseases to some types of medicine.Abstract
To investigate the evolution of SARS-CoV-2 in the immune population, we co-incubated authentic virus with a highly neutralizing plasma from a COVID-19 convalescent patient. The plasma fully neutralized the virus for 7 passages, but after 45 days, the deletion of F140 in the spike N-terminal domain (NTD) N3 loop led to partial breakthrough. At day 73, an E484K substitution in the receptor-binding domain (RBD) occurred, followed at day 80 by an insertion in the NTD N5 loop containing a new glycan sequon, which generated a variant completely resistant to plasma neutralization. Computational modeling predicts that the deletion and insertion in loops N3 and N5 prevent binding of neutralizing antibodies. The recent emergence in the United Kingdom and South Africa of natural variants with similar changes suggests that SARS-CoV-2 has the potential to escape an effective immune response and that vaccines and antibodies able to control emerging variants should be developed."
Another comment: while the article argues for the need to develop new vaccines, they do not mention the human body and its immune system; understandably so, since there would be less grant money and less business for the industry.